UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multicenter study on costs associated with two surgical procedures: GreenLight XPS 180 W versus the gold standard transurethral resection of the prostate

Actas urologicas españolas, 2014-07, Vol.38 (6), p.373-377

2014

Volltextzugriff (PDF)

Análisis probabilístico de minimización de costes de darbepoetin alfa frente a epoetina alfa en el tratamiento de la anemia secundaria a insuficiencia renal crónica. Valoración en la práctica clínica española

Farmacia hospitalaria, 2009-07, Vol.33 (4), p.208-216

Sanz Granda, A

2009

Volltextzugriff (PDF)

PND19 Pharmacological Costs of Recurrent-Remitent Multiple Sclerosis Treatment in Spain

Value in health, 2012-11, Vol.15 (7), p.A549-A549

2012

Volltextzugriff (PDF)

Cost-utility analysis of two formulations of botulinum toxin type A in the treatment of blepharospasm and cervical dystonia in Spain

Revista de neurologiá, 2018-12, Vol.67 (12), p.465-472

2018

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Surgical Management of Stress Urinary Incontinence With Single-Incision Mini-Sling Versus Tension-Free Vaginal Obturator in Spain

Value in health, 2014-11, Vol.17 (7), p.A509-A509

2014

Volltextzugriff (PDF)

Los modelos de decisión como herramienta de evaluación de intervenciones sanitarias

Farmacéuticos comunitarios, 2018-03, Vol.5 (1), p.13-19

Sanz Granda A.

2018

Volltextzugriff (PDF)

Tipos de resultados en evaluación económica de las intervenciones farmacéuticas

Farmacéuticos comunitarios, 2012-06, Vol.4 (2), p.72-76

Sanz Granda, Ángel

2012

Volltextzugriff (PDF)

Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain

Revista de neurologiá, 2012-04, Vol.54 (7), p.446-7; author reply 447-8

2012

Volltextzugriff (PDF)

Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

Value in health, 2016-11, Vol.19 (7), p.A433-A433

Sanz-Granda, Á

2016

Volltextzugriff (PDF)

PND47 - Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

Value in health, 2016-11, Vol.19 (7), p.A433-A433

Sanz-Granda, Á

2016

Volltextzugriff (PDF)

Los costes en la evaluación de intervenciones farmacéuticas. Los costes en farmacoeconomía

Farmacéuticos comunitarios, 2011-12, Vol.3 (4), p.166-169

Granda, Ángel Sanz

2011

Volltextzugriff (PDF)

Retribución en farmacia comunitaria. Visión en otros países

Farmacéuticos comunitarios, 2011-09, Vol.3 (3), p.120-126

2011

Volltextzugriff (PDF)

Propuesta de sistema retributivo de SEFAC para la prestación del servicio de dispensación al Sistema Nacional de Salud

Farmacéuticos comunitarios, 2012-12, Vol.4 (4), p.146-164

2012

Volltextzugriff (PDF)

PRS15 - Reduction of Costs Associated with a New Dry-Powder Inhaler Formulation with Beclomethasone Dipropionate and Formoterol Combination for the Treatment of Asthma

Value in health, 2013-11, Vol.16 (7), p.A368-A368

2013

Volltextzugriff (PDF)

PCN194 - ESTIMATION OF THE TRESHOLD PRICE OF REGORAFENIB IN THE TREATMENT OF UNRESECTABLE AND/OR METASTATIC GASTROINTESTINAL STROMAL TUMORS AFTER FAILURE ON IMATINIB AND SUNITINIB IN SPAIN: COST-UTILITY ANALYSIS

Value in health, 2015-11, Vol.18 (7), p.A464-A464

2015

Volltextzugriff (PDF)

ESTIMATION OF THE TRESHOLD PRICE OF REGORAFENIB IN THE TREATMENT OF UNRESECTABLE AND/OR METASTATIC GASTROINTESTINAL STROMAL TUMORS AFTER FAILURE ON IMATINIB AND SUNITINIB IN SPAIN: COST-UTILITY ANALYSIS

Value in health, 2015-11, Vol.18 (7), p.A464-A464

2015

Volltextzugriff (PDF)

Reduction of Costs Associated with a New Dry-Powder Inhaler Formulation with Beclomethasone Dipropionate and Formoterol Combination for the Treatment of Asthma

Value in health, 2013-11, Vol.16 (7), p.A368-A368

2013

Volltextzugriff (PDF)

Análisis coste efectividad a 2 años del tratamiento quirúrgico de la hiperplasia benigna de próstata mediante vaporización fotoselectiva de la próstata con GreenLight–PhotoVaporization 120W versus resección transuretral de la próstata

Actas urologicas españolas, 2014-05, Vol.38 (4), p.238-243

2014

Volltextzugriff (PDF)

PUK5 - Budget Impact of Switching From an Extended-Release to an Immediate-Release Formulation of Tacrolimus in Renal Transplant Recipients in Spain

Value in health, 2016-11, Vol.19 (7), p.A517-A517

2016

Volltextzugriff (PDF)

Budget Impact of Switching From an Extended-Release to an Immediate-Release Formulation of Tacrolimus in Renal Transplant Recipients in Spain

Value in health, 2016-11, Vol.19 (7), p.A517-A517

2016

Volltextzugriff (PDF)

PSS14 - Economic Burden of Burn Injuries Treated With An Enzymatic Debriding Agent In Spain

Value in health, 2017-10, Vol.20 (9), p.A803-A803

2017

Volltextzugriff (PDF)

Economic Burden of Burn Injuries Treated With An Enzymatic Debriding Agent In Spain

Value in health, 2017-10, Vol.20 (9), p.A803

2017

Volltextzugriff (PDF)

Increased Clinical and Economic Benefit in Spain Associated with Improvement to ±8.5% of The Accuracy of Glucose Meters Adapted to The Current ISO 15197:2013 (±15%)

Value in health, 2016-11, Vol.19 (7), p.A689-A689

2016

Volltextzugriff (PDF)

PMD28 - Increased Clinical and Economic Benefit in Spain Associated with Improvement to ±8.5% of The Accuracy of Glucose Meters Adapted to The Current ISO 15197:2013 (±15%)

Value in health, 2016-11, Vol.19 (7), p.A689-A689

2016

Volltextzugriff (PDF)

PCN169 - Pharmacoeconomic Assessment Of Pegaspargase Versus Asparaginase in Acute Lymphocytic Leukemia

Value in health, 2016-11, Vol.19 (7), p.A739-A739

2016

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(57)

Sprache

Erscheinungsjahr

n.n

Thema

Internal Medicine
(10)
Humans
(6)
Science & Technology
(6)
Benign Prostate Hyperplasia
(4)
Hiperplasia Benigna De Próstata
(4)
Life Sciences & Biomedicine
(4)
Resección Transuretral De La Próstata
(4)
Transurethral Resection Of The Prostate
(4)
Urology
(4)
Cost-Benefit Analysis
(3)
Cost-Effectiveness
(3)
Aged
(2)
Anaemia
(2)
Anemia
(2)
Antineoplastic Agents - Economics
(2)
Burns
(2)
Chronic Renal Failure
(2)
Clinical Neurology
(2)
Cost
(2)
Cost Minimisation
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicenter study on costs associated with two surgical procedures: GreenLight XPS 180 W versus the gold standard transurethral resection of the prostate

Análisis probabilístico de minimización de costes de darbepoetin alfa frente a epoetina alfa en el tratamiento de la anemia secundaria a insuficiencia renal crónica. Valoración en la práctica clínica española

PND19 Pharmacological Costs of Recurrent-Remitent Multiple Sclerosis Treatment in Spain

Cost-utility analysis of two formulations of botulinum toxin type A in the treatment of blepharospasm and cervical dystonia in Spain

Cost-Effectiveness Analysis of Surgical Management of Stress Urinary Incontinence With Single-Incision Mini-Sling Versus Tension-Free Vaginal Obturator in Spain

Los modelos de decisión como herramienta de evaluación de intervenciones sanitarias

Tipos de resultados en evaluación económica de las intervenciones farmacéuticas

Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain

Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

PND47 - Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

Los costes en la evaluación de intervenciones farmacéuticas. Los costes en farmacoeconomía

Retribución en farmacia comunitaria. Visión en otros países

Propuesta de sistema retributivo de SEFAC para la prestación del servicio de dispensación al Sistema Nacional de Salud

PRS15 - Reduction of Costs Associated with a New Dry-Powder Inhaler Formulation with Beclomethasone Dipropionate and Formoterol Combination for the Treatment of Asthma

PCN194 - ESTIMATION OF THE TRESHOLD PRICE OF REGORAFENIB IN THE TREATMENT OF UNRESECTABLE AND/OR METASTATIC GASTROINTESTINAL STROMAL TUMORS AFTER FAILURE ON IMATINIB AND SUNITINIB IN SPAIN: COST-UTILITY ANALYSIS

ESTIMATION OF THE TRESHOLD PRICE OF REGORAFENIB IN THE TREATMENT OF UNRESECTABLE AND/OR METASTATIC GASTROINTESTINAL STROMAL TUMORS AFTER FAILURE ON IMATINIB AND SUNITINIB IN SPAIN: COST-UTILITY ANALYSIS

Reduction of Costs Associated with a New Dry-Powder Inhaler Formulation with Beclomethasone Dipropionate and Formoterol Combination for the Treatment of Asthma

Análisis coste efectividad a 2 años del tratamiento quirúrgico de la hiperplasia benigna de próstata mediante vaporización fotoselectiva de la próstata con GreenLight–PhotoVaporization 120W versus resección transuretral de la próstata

PUK5 - Budget Impact of Switching From an Extended-Release to an Immediate-Release Formulation of Tacrolimus in Renal Transplant Recipients in Spain

Budget Impact of Switching From an Extended-Release to an Immediate-Release Formulation of Tacrolimus in Renal Transplant Recipients in Spain

PSS14 - Economic Burden of Burn Injuries Treated With An Enzymatic Debriding Agent In Spain

Economic Burden of Burn Injuries Treated With An Enzymatic Debriding Agent In Spain

Increased Clinical and Economic Benefit in Spain Associated with Improvement to ±8.5% of The Accuracy of Glucose Meters Adapted to The Current ISO 15197:2013 (±15%)

PMD28 - Increased Clinical and Economic Benefit in Spain Associated with Improvement to ±8.5% of The Accuracy of Glucose Meters Adapted to The Current ISO 15197:2013 (±15%)

PCN169 - Pharmacoeconomic Assessment Of Pegaspargase Versus Asparaginase in Acute Lymphocytic Leukemia

Suchergebnisse filtern